Literature DB >> 18547236

Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes.

.   

Abstract

OBJECTIVE: Adiponectin, an adipokine secreted by the adipocyte, is inversely related to adiposity and directly related to insulin sensitivity. In type 1 diabetes mellitus (T1DM), however, data thus far are contradictory. We investigated the relationship between adiponectin and exercise inT1DM.
METHODS: Forty-nine children (14.5 +/- 2.0 yr, range 8-17 yr) with T1DM on an insulin pump were studied during two 75-min exercise sessions with and without continuation of the basal rate within 4 wk. Adiponectin and epinephrine concentrations were measured before and during exercise.
RESULTS: Mean preexercise adiponectin concentration was 11.2 +/- 4.7 mg/L (range 2.7-23.0 mg/L) with a mean absolute difference of 1.7 mg/L between the 2 d. Adiponectin concentrations did not change meaningfully during exercise (mean change: -0.1 +/- 1.2 mg/L; p = 0.17). Adiponectin correlated inversely with body mass index percentile (p = 0.02) but not with age, gender, duration of diabetes, hemoglobin A1c, or preexercise glucose. However, those with higher baseline adiponectin concentrations were less likely to become hypoglycemic during exercise, 36% becoming hypoglycemic when baseline adiponectin concentration was <10 mg/L, 42% when 10 to <15 mg/L, and 15% when > or =15 mg/L (p = 0.02). Baseline epinephrine concentrations were not associated with adiponectin, and in those whose nadir glucose was < or =100 mg/dL, there was no correlation between epinephrine response and adiponectin (p = 0.16).
CONCLUSIONS: Adiponectin concentrations are stable from day to day, are not affected by acute exercise or metabolic control, and vary inversely with adiposity. Higher adiponectin concentration appears to be associated with a decrease in hypoglycemia risk during exercise. Further studies are needed to examine whether adiponectin protects against exercise-induced hypoglycemia by directly enhancing the oxidation of alternate fuels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547236      PMCID: PMC2435370          DOI: 10.1111/j.1399-5448.2008.00372.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  17 in total

1.  The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T Costacou; J C Zgibor; R W Evans; J Otvos; M F Lopes-Virella; R P Tracy; T J Orchard
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

2.  The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals.

Authors:  Philip W Peake; Adamandia D Kriketos; Lesley V Campbell; Yvonne Shen; John A Charlesworth
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

3.  Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

Authors:  Markku Saraheimo; Carol Forsblom; Johan Fagerudd; Anna-Maija Teppo; Kim Pettersson-Fernholm; Jan Frystyk; Allan Flyvbjerg; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

4.  Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974).

Authors:  R B Passey; R L Gillum; J B Fuller; F M Urry; M L Giles
Journal:  Clin Chem       Date:  1977-01       Impact factor: 8.327

5.  Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.

Authors:  Eva Tsalikian; Craig Kollman; William B Tamborlane; Roy W Beck; Rosanna Fiallo-Scharer; Larry Fox; Kathleen F Janz; Katrina J Ruedy; Darrell Wilson; Dongyuan Xing; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

6.  Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.

Authors:  S Hadjadj; R Aubert; F Fumeron; F Pean; J Tichet; R Roussel; M Marre
Journal:  Diabetologia       Date:  2005-05-05       Impact factor: 10.122

7.  Low plasma adiponectin levels predict progression of coronary artery calcification.

Authors:  David M Maahs; Lorraine G Ogden; Gregory L Kinney; Paul Wadwa; Janet K Snell-Bergeon; Dana Dabelea; John E Hokanson; James Ehrlich; Robert H Eckel; Marian Rewers
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

8.  Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

Authors:  S A Amiel; R S Sherwin; D C Simonson; A A Lauritano; W V Tamborlane
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

9.  Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.

Authors:  A Schäffler; H Herfarth; G Paul; A Ehling; U Müller-Ladner; J Schölmerich; B Zietz
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-07       Impact factor: 2.949

10.  Independent effects of youth and poor diabetes control on responses to hypoglycemia in children.

Authors:  T W Jones; S D Boulware; D T Kraemer; S Caprio; R S Sherwin; W V Tamborlane
Journal:  Diabetes       Date:  1991-03       Impact factor: 9.461

View more
  2 in total

1.  Diabetes research in children network:availability of protocol data sets.

Authors:  Katrina J Ruedy; Roy W Beck; Dongyuan Xing; Craig Kollman
Journal:  J Diabetes Sci Technol       Date:  2007-09

2.  The Effect of Metabolic Profile on Leptin, Adiponectin, and hs-CRP in Children and Adolescents with Type 1 Diabetes.

Authors:  Maria Kaza; Charalampos Tsentidis; Elpis Vlachopapadopoulou; Irine-Ikbale Sakou; Spyridon Karanasios; George Mastorakos; Kyriaki Karavanaki
Journal:  Children (Basel)       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.